MedTrace Logo

Hypolipidemic and Antioxidant Capacity of Spirulina and Exercise

NCT02837666 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2019-11-13

No results posted yet for this study

Summary

The purpose of this study is to demonstrate that Spirulina maxima intake and a dosed physical activity program will decrease, both independently and synergistically, cardiovascular risks (Dyslipidemias and oxidative stress) in overweight and obese subjects.

Conditions

Interventions

DIETARY_SUPPLEMENT

Supplementation with Spirulina maxima

Supplementation with Spirulina maxima (4.5 g/d) in capsules during 6 weeks.

OTHER

Washout

2 weeks washout period to each study subject to avoid any possible carryover effect.

OTHER

Supplementation with placebo

Supplementation with placebo (4.5 g/d) in capsules during 6 weeks.

OTHER

Isoenergetic diet

All participants will have a personal isoenergetic diet according to their height, weight, body composition and daily physical activity during 14 weeks

OTHER

Exercise program

Participants are going to exercise five days a week with the following protocol: Between 5 and 10 min of heating exercise, Between 20-30 min anaerobic exercise and 20-30 min of aerobic exercise (cardiovascular exercise): walking, jogging, running and/or cycling, Three days a week aerobic intensities will be between 60% and 80% and two days between 70% and 90% of the maximum heart rate reserve, and five final minutes of stretching.

Sponsors & Collaborators

  • Universidad Autonoma de Ciudad Juarez

    lead OTHER

Principal Investigators

  • Marco A Hernandez-Lepe, MS · Universidad Autonoma de Ciudad Juarez

  • Arnulfo Ramos-Jimenez, phD · Universidad Autonoma de Ciudad Juarez

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-04
Primary Completion
2017-09-30
Completion
2017-12-10

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02837666 on ClinicalTrials.gov